Effects  ||| S:0 E:8 ||| NNS
of  ||| S:8 E:11 ||| IN
low-intensity  ||| S:11 E:25 ||| JJ
pulsed  ||| S:25 E:32 ||| JJ
ultrasound  ||| S:32 E:43 ||| NN
on  ||| S:43 E:46 ||| IN
bone  ||| S:46 E:51 ||| NN
formation  ||| S:51 E:61 ||| NN
after  ||| S:61 E:67 ||| IN
the  ||| S:67 E:71 ||| DT
expansion  ||| S:71 E:81 ||| NN
of  ||| S:81 E:84 ||| IN
the  ||| S:84 E:88 ||| DT
inter-premaxillary  ||| S:88 E:107 ||| JJ
suture  ||| S:107 E:114 ||| NN
in  ||| S:114 E:117 ||| IN
rats ||| S:117 E:121 ||| NNS
:  ||| S:121 E:123 ||| :
a  ||| S:123 E:125 ||| DT
histologic  ||| S:125 E:136 ||| NN
and  ||| S:136 E:140 ||| CC
immunohistochemical  ||| S:140 E:160 ||| JJ
study  ||| S:160 E:166 ||| NN
Orthodontic  ||| S:166 E:178 ||| NNP
maxillary  ||| S:178 E:188 ||| JJ
expansion  ||| S:188 E:198 ||| NN
is  ||| S:198 E:201 ||| VBZ
a  ||| S:201 E:203 ||| DT
commonly-performed  ||| S:203 E:222 ||| JJ
treatment  ||| S:222 E:232 ||| NN
approach  ||| S:232 E:241 ||| NN
to  ||| S:241 E:244 ||| TO
correct  ||| S:244 E:252 ||| VB
transverse  ||| S:252 E:263 ||| JJ
maxillary  ||| S:263 E:273 ||| JJ
deficiencies  ||| S:273 E:286 ||| NNS
by  ||| S:286 E:289 ||| IN
separating  ||| S:289 E:300 ||| VBG
the  ||| S:300 E:304 ||| DT
mid-palatal  ||| S:304 E:316 ||| JJ
suture ||| S:316 E:322 ||| NN
.  ||| S:322 E:324 ||| .
To  ||| S:324 E:327 ||| TO
obtain  ||| S:327 E:334 ||| VB
a  ||| S:334 E:336 ||| DT
successful  ||| S:336 E:347 ||| JJ
treatment  ||| S:347 E:357 ||| NN
result  ||| S:357 E:364 ||| NN
and  ||| S:364 E:368 ||| CC
prevent  ||| S:368 E:376 ||| VB
relapse ||| S:376 E:383 ||| NNS
,  ||| S:383 E:385 ||| ,
the  ||| S:385 E:389 ||| DT
expanded  ||| S:389 E:398 ||| JJ
maxillary  ||| S:398 E:408 ||| JJ
sutures  ||| S:408 E:416 ||| NNS
require  ||| S:416 E:424 ||| VBP
maintenance  ||| S:424 E:436 ||| NN
by  ||| S:436 E:439 ||| IN
means  ||| S:439 E:445 ||| NNS
of  ||| S:445 E:448 ||| IN
qualified  ||| S:448 E:458 ||| JJ
bone  ||| S:458 E:463 ||| NN
reorganisation ||| S:463 E:477 ||| NN
.  ||| S:477 E:479 ||| .
To  ||| S:479 E:482 ||| TO
assess  ||| S:482 E:489 ||| VB
the  ||| S:489 E:493 ||| DT
effects  ||| S:493 E:501 ||| NNS
of  ||| S:501 E:504 ||| IN
low-intensity  ||| S:504 E:518 ||| JJ
pulsed  ||| S:518 E:525 ||| JJ
ultrasound  ||| S:525 E:536 ||| NN
( ||| S:536 E:537 ||| -LRB-
LIPUS ||| S:537 E:542 ||| NNP
)  ||| S:542 E:544 ||| -RRB-
on  ||| S:544 E:547 ||| IN
sutural  ||| S:547 E:555 ||| JJ
bone  ||| S:555 E:560 ||| NN
formation  ||| S:560 E:570 ||| NN
after  ||| S:570 E:576 ||| IN
the  ||| S:576 E:580 ||| DT
expansion  ||| S:580 E:590 ||| NN
of  ||| S:590 E:593 ||| IN
the  ||| S:593 E:597 ||| DT
interpremaxillary  ||| S:597 E:615 ||| JJ
suture  ||| S:615 E:622 ||| NN
in  ||| S:622 E:625 ||| IN
rats ||| S:625 E:629 ||| NNS
.  ||| S:629 E:631 ||| .
Sixteen  ||| S:631 E:639 ||| JJ
male  ||| S:639 E:644 ||| JJ
Wistar  ||| S:644 E:651 ||| JJ
rats ||| S:651 E:655 ||| NNS
,  ||| S:655 E:657 ||| ,
6  ||| S:657 E:659 ||| CD
to  ||| S:659 E:662 ||| TO
8-week  ||| S:662 E:669 ||| CD
old ||| S:669 E:672 ||| JJ
,  ||| S:672 E:674 ||| ,
were  ||| S:674 E:679 ||| VBD
used ||| S:679 E:683 ||| VBN
.  ||| S:683 E:685 ||| .
The  ||| S:685 E:689 ||| DT
expansion  ||| S:689 E:699 ||| NN
appliance  ||| S:699 E:709 ||| NN
comprised  ||| S:709 E:719 ||| VBD
a  ||| S:719 E:721 ||| DT
helical  ||| S:721 E:729 ||| JJ
spring  ||| S:729 E:736 ||| NN
fabricated  ||| S:736 E:747 ||| VBN
from  ||| S:747 E:752 ||| IN
0.014  ||| S:752 E:758 ||| CD
inch  ||| S:758 E:763 ||| NN
stainless  ||| S:763 E:773 ||| NN
steel  ||| S:773 E:779 ||| NN
wire  ||| S:779 E:784 ||| NN
( ||| S:784 E:785 ||| -LRB-
Dentaurum ||| S:785 E:794 ||| NNP
,  ||| S:794 E:796 ||| ,
Ispringen ||| S:796 E:805 ||| NNP
,  ||| S:805 E:807 ||| ,
Germany ||| S:807 E:814 ||| NNP
) ||| S:814 E:815 ||| -RRB-
.  ||| S:815 E:817 ||| .
The  ||| S:817 E:821 ||| DT
rats  ||| S:821 E:826 ||| NNS
were  ||| S:826 E:831 ||| VBD
divided  ||| S:831 E:839 ||| VBN
into  ||| S:839 E:844 ||| IN
two  ||| S:844 E:848 ||| CD
equal  ||| S:848 E:854 ||| JJ
groups  ||| S:854 E:861 ||| NNS
and  ||| S:861 E:865 ||| CC
randomly  ||| S:865 E:874 ||| RB
assigned  ||| S:874 E:883 ||| VBN
to  ||| S:883 E:886 ||| TO
the  ||| S:886 E:890 ||| DT
LIPUS  ||| S:890 E:896 ||| NNP
treatment  ||| S:896 E:906 ||| NN
group  ||| S:906 E:912 ||| NN
or  ||| S:912 E:915 ||| CC
a  ||| S:915 E:917 ||| DT
sham-operation  ||| S:917 E:932 ||| JJ
group ||| S:932 E:937 ||| NN
.  ||| S:937 E:939 ||| .
LIPUS  ||| S:939 E:945 ||| NNP
was  ||| S:945 E:949 ||| VBD
delivered  ||| S:949 E:959 ||| VBN
via  ||| S:959 E:963 ||| IN
a  ||| S:963 E:965 ||| DT
2.5  ||| S:965 E:969 ||| CD
cm  ||| S:969 E:972 ||| FW
diameter  ||| S:972 E:981 ||| FW
ultrasound  ||| S:981 E:992 ||| FW
transducer  ||| S:992 E:1003 ||| FW
( ||| S:1003 E:1004 ||| -LRB-
Exogen ||| S:1004 E:1010 ||| NNP
,  ||| S:1010 E:1012 ||| ,
Smith  ||| S:1012 E:1018 ||| NNP
and  ||| S:1018 E:1022 ||| CC
Nephews ||| S:1022 E:1029 ||| NNP
,  ||| S:1029 E:1031 ||| ,
Inc. ||| S:1031 E:1035 ||| NNP
,  ||| S:1035 E:1037 ||| ,
Memphis ||| S:1037 E:1044 ||| NNP
,  ||| S:1044 E:1046 ||| ,
TN ||| S:1046 E:1048 ||| NNP
,  ||| S:1048 E:1050 ||| ,
USA ||| S:1050 E:1053 ||| NNP
)  ||| S:1053 E:1055 ||| -RRB-
for  ||| S:1055 E:1059 ||| IN
20  ||| S:1059 E:1062 ||| CD
minutes  ||| S:1062 E:1070 ||| NNS
per  ||| S:1070 E:1074 ||| IN
day  ||| S:1074 E:1078 ||| NN
during  ||| S:1078 E:1085 ||| IN
7  ||| S:1085 E:1087 ||| CD
days  ||| S:1087 E:1092 ||| NNS
of  ||| S:1092 E:1095 ||| IN
post-expansion  ||| S:1095 E:1110 ||| JJ
retention ||| S:1110 E:1119 ||| NN
.  ||| S:1119 E:1121 ||| .
Following  ||| S:1121 E:1131 ||| VBG
retention ||| S:1131 E:1140 ||| NN
,  ||| S:1140 E:1142 ||| ,
the  ||| S:1142 E:1146 ||| DT
rats ||| S:1146 E:1150 ||| NN
'  ||| S:1150 E:1152 ||| POS
maxillae  ||| S:1152 E:1161 ||| NN
were  ||| S:1161 E:1166 ||| VBD
surgically  ||| S:1166 E:1177 ||| RB
removed  ||| S:1177 E:1185 ||| VBN
and  ||| S:1185 E:1189 ||| CC
histologic  ||| S:1189 E:1200 ||| NNS
and  ||| S:1200 E:1204 ||| CC
immunohistochemical  ||| S:1204 E:1224 ||| JJ
specimens  ||| S:1224 E:1234 ||| NNS
were  ||| S:1234 E:1239 ||| VBD
prepared  ||| S:1239 E:1248 ||| VBN
and  ||| S:1248 E:1252 ||| CC
examined ||| S:1252 E:1260 ||| VBD
.  ||| S:1260 E:1262 ||| .
The  ||| S:1262 E:1266 ||| DT
number  ||| S:1266 E:1273 ||| NN
of  ||| S:1273 E:1276 ||| IN
osteoblasts  ||| S:1276 E:1288 ||| NN
and  ||| S:1288 E:1292 ||| CC
blood  ||| S:1292 E:1298 ||| NN
vessel  ||| S:1298 E:1305 ||| NN
dimensions  ||| S:1305 E:1316 ||| NNS
in  ||| S:1316 E:1319 ||| IN
the  ||| S:1319 E:1323 ||| DT
ultrasound  ||| S:1323 E:1334 ||| NN
group  ||| S:1334 E:1340 ||| NN
increased  ||| S:1340 E:1350 ||| VBN
but  ||| S:1350 E:1354 ||| CC
was  ||| S:1354 E:1358 ||| VBD
not  ||| S:1358 E:1362 ||| RB
significant ||| S:1362 E:1373 ||| JJ
,  ||| S:1373 E:1375 ||| ,
compared  ||| S:1375 E:1384 ||| VBN
with  ||| S:1384 E:1389 ||| IN
the  ||| S:1389 E:1393 ||| DT
control  ||| S:1393 E:1401 ||| NN
group ||| S:1401 E:1406 ||| NN
.  ||| S:1406 E:1408 ||| .
A  ||| S:1408 E:1410 ||| DT
statistically  ||| S:1410 E:1424 ||| JJ
significant  ||| S:1424 E:1436 ||| JJ
difference  ||| S:1436 E:1447 ||| NN
in  ||| S:1447 E:1450 ||| IN
osteocalcin ||| S:1450 E:1461 ||| NN
,  ||| S:1461 E:1463 ||| ,
VEGF  ||| S:1463 E:1468 ||| NNP
and  ||| S:1468 E:1472 ||| CC
TGF-β  ||| S:1472 E:1478 ||| JJ
immunoreactivities  ||| S:1478 E:1497 ||| NNS
( ||| S:1497 E:1498 ||| -LRB-
p  ||| S:1498 E:1500 ||| CD
< ||| S:1500 E:1502 ||| SYM
0.01 ||| S:1502 E:1506 ||| CD
)  ||| S:1506 E:1508 ||| -RRB-
was  ||| S:1508 E:1512 ||| VBD
found  ||| S:1512 E:1518 ||| VBN
in  ||| S:1518 E:1521 ||| IN
the  ||| S:1521 E:1525 ||| DT
area  ||| S:1525 E:1530 ||| NN
of  ||| S:1530 E:1533 ||| IN
the  ||| S:1533 E:1537 ||| DT
mineralising  ||| S:1537 E:1550 ||| JJ
tissue ||| S:1550 E:1556 ||| NN
.  ||| S:1556 E:1558 ||| .
Only  ||| S:1558 E:1563 ||| RB
VEGF  ||| S:1563 E:1568 ||| JJ
immunoreactivity  ||| S:1568 E:1585 ||| NN
was  ||| S:1585 E:1589 ||| VBD
significant  ||| S:1589 E:1601 ||| JJ
between  ||| S:1601 E:1609 ||| IN
two  ||| S:1609 E:1613 ||| CD
groups  ||| S:1613 E:1620 ||| NNS
( ||| S:1620 E:1621 ||| -LRB-
p  ||| S:1621 E:1623 ||| CD
< ||| S:1623 E:1625 ||| SYM
0.01 ||| S:1625 E:1629 ||| CD
)  ||| S:1629 E:1631 ||| -RRB-
in  ||| S:1631 E:1634 ||| IN
the  ||| S:1634 E:1638 ||| DT
fibrous  ||| S:1638 E:1646 ||| JJ
tissue  ||| S:1646 E:1653 ||| NN
area ||| S:1653 E:1657 ||| NN
.  ||| S:1657 E:1659 ||| .
The  ||| S:1659 E:1663 ||| DT
area  ||| S:1663 E:1668 ||| NN
of  ||| S:1668 E:1671 ||| IN
mineralising  ||| S:1671 E:1684 ||| JJ
tissue  ||| S:1684 E:1691 ||| NN
in  ||| S:1691 E:1694 ||| IN
the  ||| S:1694 E:1698 ||| DT
LIPUS-applied  ||| S:1698 E:1712 ||| JJ
group  ||| S:1712 E:1718 ||| NN
expressed  ||| S:1718 E:1728 ||| VBD
activity  ||| S:1728 E:1737 ||| NN
markers  ||| S:1737 E:1745 ||| NN
for  ||| S:1745 E:1749 ||| IN
osteocalcin ||| S:1749 E:1760 ||| NN
,  ||| S:1760 E:1762 ||| ,
VEGF  ||| S:1762 E:1767 ||| NNP
and  ||| S:1767 E:1771 ||| CC
TGF-β  ||| S:1771 E:1777 ||| JJ
compared  ||| S:1777 E:1786 ||| VBN
with  ||| S:1786 E:1791 ||| IN
a  ||| S:1791 E:1793 ||| DT
surrounding  ||| S:1793 E:1805 ||| JJ
area  ||| S:1805 E:1810 ||| NN
of  ||| S:1810 E:1813 ||| IN
fibrous  ||| S:1813 E:1821 ||| JJ
tissue ||| S:1821 E:1827 ||| NN
.  ||| S:1827 E:1829 ||| .
Cellular  ||| S:1829 E:1838 ||| JJ
activation  ||| S:1838 E:1849 ||| NN
in  ||| S:1849 E:1852 ||| IN
the  ||| S:1852 E:1856 ||| DT
LIPUS  ||| S:1856 E:1862 ||| NNP
group  ||| S:1862 E:1868 ||| NN
was  ||| S:1868 E:1872 ||| VBD
greater  ||| S:1872 E:1880 ||| JJR
than  ||| S:1880 E:1885 ||| IN
that  ||| S:1885 E:1890 ||| DT
of  ||| S:1890 E:1893 ||| IN
controls ||| S:1893 E:1901 ||| NNS
.  ||| S:1901 E:1903 ||| .
Therefore ||| S:1903 E:1912 ||| RB
,  ||| S:1912 E:1914 ||| ,
LIPUS  ||| S:1914 E:1920 ||| NNP
may  ||| S:1920 E:1924 ||| MD
be  ||| S:1924 E:1927 ||| VB
accepted  ||| S:1927 E:1936 ||| VBN
as  ||| S:1936 E:1939 ||| IN
a  ||| S:1939 E:1941 ||| DT
useful  ||| S:1941 E:1948 ||| JJ
approach  ||| S:1948 E:1957 ||| NN
to  ||| S:1957 E:1960 ||| TO
enhance  ||| S:1960 E:1968 ||| VB
sutural  ||| S:1968 E:1976 ||| JJ
bone  ||| S:1976 E:1981 ||| NN
formation ||| S:1981 E:1990 ||| NN
.  ||| S:1990 E:1992 ||| .
